The American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL, was held on the 7–10 December.
Covering it all, explore our coverage by disease type, including updates from key trials in which new agents are moving forwards, press brief presentations, late-breaking data, and beyond.
VJHemOnc are excited to present you with a rundown of the incredibly exciting late-breaking abstracts presented at this year’s meeting!
Explore our coverage of real-world data across a spectrum of hematological diseases.
Including multiple myeloma, acute lymphoblastic leukemia and myelofibrosis.
The latest results from the key trials at ASH 2019.
Watch the expert’s epxlain the data from the cutting-edge research.
Watch the press brief presentations and interviews with the researchers here!
Big research and big results, new and novel agents, CAR T-cell therapies, non-malignant pathologies, and accelerating genomics and gene therapy.
Sorry, no posts matched your criteria.
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates